Chembio Diagnostics Hit with Class Action After FDA Pulls Emergency Use Permission For COVID-19 Antibody Test
June 23, 2020 Chembio Diagnostics faces a class action centered on the FDA's revocation of an emergency use authorization for the company's COVID-19 antibody test.